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Pyrenophora teres f. sp. teres is the cause of net form of net blotch (NFNB), an
economically important foliar disease in barley (Hordeum vulgare). Net and spot forms
of net blotch are widely controlled using site-specific systemic fungicides. Although
resistance to succinate dehydrogenase inhibitors and quinone outside inhibitors has
been addressed before in net blotches, mechanisms controlling demethylation inhibitor
resistance have not yet been reported at the molecular level. Here we report the isolation
of strains of NFNB in Australia since 2013 resistant to a range of demethylase inhibitor
fungicides. Cyp51A:KO103-A1, an allele with the mutation F489L, corresponding to
the archetype F495I in Aspergillus fumigatus, was only present in resistant strains
and was correlated with resistance factors to various demethylase inhibitors ranging
from 1.1 for epoxiconazole to 31.7 for prochloraz. Structural in silico modeling of the
sensitive and resistant CYP51A proteins docked with different demethylase inhibitor
fungicides showed how the interaction of F489L within the heme cavity produced a
localized constriction of the region adjacent to the docking site that is predicted to
result in lower binding affinities. Resistant strains also displayed enhanced induced
expression of the two Cyp51A paralogs and of Cyp51B genes. While Cyp51B was
found to be constitutively expressed in the absence of fungicide, Cyp51A was only
detected at extremely low levels. Under fungicide induction, expression of Cyp51B,
Cyp51A2, and Cyp51A1 was shown to be 1.6-, 3,- and 5.3-fold higher, respectively in
the resistant isolate compared to the wild type. These increased levels of expression
were not supported by changes in the promoters of any of the three genes. The
implications of these findings on demethylase inhibitor activity will require current net
blotch management strategies to be reconsidered in order to avoid the development of
further resistance and preserve the lifespan of fungicides in use.
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INTRODUCTION
Pyrenophora teres f. sp. teres (Ptt) (P. teres Drechsler; anamorph
Drechslera teres [Sacc.] Shoem.) is a necrotrophic fungal
pathogen and the cause of net form of net blotch (NFNB)
that, together with spot form of net blotch (SFNB), is one
of the most important diseases of barley (Hordeum vulgare).
Worldwide, net blotches are commonly responsible for barley
yield losses of 10–40%, and in some cases losses of up to 100%
can occur (Liu et al., 2011). NFNB is a major disease of most
barley growing regions including Europe (Leišova et al., 2005;
Serenius et al., 2007; Ficsor et al., 2014), North America (Tekauz,
1990; Steffenson et al., 1991), and North Africa (Boungab
et al., 2012). In Australia, the value of disease control for
NFNB is estimated at $98 million annually with average direct
costs of $19 million annually, making it the most significant
necrotrophic barley disease after SFNB (Murray and Brennan,
2010). Along with cultural practices, the main control measures
are the application of effective fungicides and the use of cultivars
with genetic resistance. However, due to the lack of highly
resistant cultivars, net blotch diseases are mainly controlled
using fungicides (Sierotzki et al., 2007). Fungicides of the
quinone outside inhibitor (QoI) and the succinate dehydrogenase
inhibitor (SDHI) classes are used in the control of Ptt, especially
in Europe, where mutations in the respective target genes
cytochrome b and the succinate dehydrogenase complex (SdhB,
SdhC, and SdhD) associated with resistance in Ptt have now
been widely reported (Semar et al., 2007; Sierotzki et al., 2007;
Rehfus et al., 2016). In Australia, the fungicides used against Ptt
are predominantly of the azole or demethylase inhibitor (DMI)
group (APVMA, 2016).
The DMIs are a group of site-specific systemic fungicides
and are the most important compounds used for the control of
fungal pathogens in both medicine and agriculture (Becher and
Wirsel, 2012; Ishii and Hollomon, 2015). This fungicide class is
comprised of a large number of structurally diverse compounds,
all having in common the presence of a N-substituted five or
six-membered heterocyclic ring (Hof, 2001). The target site of
all DMIs is the enzyme CYP51, a cytochrome P450 sterol 14α-
demethylase essential to the biosynthesis of fungal sterols (López-
Ruiz et al., 2010). Ergosterol is the most common sterol in
fungi, being a vital component of the fungal cell membrane and
essential for fungal growth (Köllerm, 2003).
Many cases of resistance to DMI fungicides have been
documented in phytopathogenic fungi (Délye et al., 1997;
Erickson and Wilcox, 1997; Fraaije et al., 2007; Ghosoph et al.,
2007; Omrane et al., 2015). Acquired resistance to DMIs has also
been widely reported in fungal pathogens of humans (Kanafani
and Perfect, 2008; Morio et al., 2010; Howard and Arendrup,
2011; Becher and Wirsel, 2012). In filamentous fungi there are
three principle known mechanisms of resistance; (1) target site
modification, where point mutations in the Cyp51 gene result
in amino acid substitutions altering the structure of the CYP51
protein, and thus reducing the binding affinity of the fungicide to
the enzyme. Point mutations have been observed to cause varying
levels of cross resistance to different DMIs (Cools and Fraaije,
2013); (2) overexpression of the target gene(s) Cyp51. Increased
production of the CYP51 enzyme results in a general reduction
of sensitivity across all the DMIs (Ishii and Hollomon, 2015);
(3) increased eﬄux by overexpression of membrane-bound drug
transporters, reducing the accumulation of fungicide at the target
site. Enhanced eﬄux tends to result in a phenotype of broad-
spectrum resistance across the DMIs and unrelated fungicide
classes (Ishii and Hollomon, 2015).
Several species of Ascomycete fungi have been shown to carry
multiple Cyp51 paralogs, including Aspergillus spp., Fusarium
spp., Penicillium digitatum, and Rhynchosporium commune
(Becher et al., 2011; Hawkins et al., 2014). Cyp51B is carried
by all ascomycetes. Some species also carry a paralog termed
Cyp51A (Becher et al., 2011). In species with three Cyp51 genes,
the third Cyp51 is either a duplicated copy of Cyp51A (as in A.
flavus and A. oryzae) or of Cyp51B (as in A. terreus) or a unique
paralog termed Cyp51C (in Fusarium spp.) (Becher et al., 2011).
In R. commune one of the Cyp51 paralogs is a pseudogenized
duplication of Cyp51A termed Cyp51A-p (Hawkins et al., 2014).
In fungi with multiple Cyp51 paralogs, Cyp51-mediated azole
resistance is often associated with mutations in or overexpression
of the Cyp51A gene (Fan et al., 2013; Brunner et al., 2015).
For example, in A. fumigatus mutations correlated with DMI
resistance have been found only in theCyp51A paralog and not in
Cyp51B (Becher et al., 2011). Resistance to DMIs in A. fumigatus
is also mediated by overexpression of the Cyp51A paralog,
which in combination with mutations in Cyp51A results in
cross-resistance (Mellado et al., 2007). Similarly, overexpression
of the Cyp51A gene but not Cyp51B has been demonstrated
as a mechanism for azole resistance in A. flavus, A. niger,
A. parasiticus, and Magnaporthe oryzae (Yan et al., 2011; Fan
et al., 2013). In P. digitatum, azole resistance has been shown
to result from the overexpression of both Cyp51A and Cyp51B
(Sun et al., 2013). In R. commune, azole resistance is associated
with the presence of Cyp51A (Hawkins et al., 2014). An analysis
of R. commune isolates showed no correlation between Cyp51B
sequence and azole sensitivity, so the authors hypothesized
that the selection pressure of azoles is driving the observed
accumulation of polymorphisms in the sequence of Cyp51A
(Brunner et al., 2015).
Resistance to the DMI fungicide triadimenol was first reported
in P. teres isolates from New Zealand (Sheridan et al., 1985).
Subsequent studies showed this phenotype emerged in both
New Zealand and the United Kingdom from the early 1980s
onwards (Sheridan et al., 1987). Crossing studies determined
that in P. teres this resistance segregated to a single major
genetic locus (Peever and Milgroom, 1992), and that resistance
to other DMIs, including propiconazole, imazalil and fenarimol,
was also genetically correlated (Peever and Milgroom, 1993).
These studies did not distinguish the net and spot types of
P. teres, although subsequent phylogenetic analysis has shown
that the two formae speciales are genetically isolated and should
be considered as distinct species (Rau et al., 2007). In Ptt
specifically, an increase in tolerance to the DMI prochloraz
has also been observed in isolates from Finland (Serenius and
Manninen, 2008).
Here we report the discovery in P. teres f. sp. teres of
resistance to multiple DMIs. Resistance was correlated with two
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genetic changes. Resistant isolates carried a novel mutation in
a copy of the Cyp51A gene. Structural analysis of the CYP51A
target revealed a strong correlation between this mutation and
the resistance levels detected. These isolates also displayed
overexpression of both copies of the Cyp51A gene as well as
overexpression of the Cyp51B.
MATERIALS AND METHODS
Fungal Isolates
The Ptt isolates used in this study are listed in Table 1.
Isolates from 1996 to 2003 were collected by the Department of
Agriculture and Food, Western Australia (South Perth, Western
Australia). Isolates from 2009 onwards were collected and
isolated by the authors from a combination of especially designed
bait trials (years 2013, 2014, and 2015) and sampling trips. Bait
trials sown with the NFNB susceptible variety Hindmarsh were
designed to work as a fungicide resistance early warning system.
2 × 4m plots were sprayed with either 1× or 2× the maximum
registered dose of the fungicides epoxiconazole, tebuconazole,
prothioconazole, and azoxystrobin, at growth stages GS31 and
GS39. Treatments were replicated three times. Leaf samples from
bait trials were collected 7 days following to the second spray
application.
Lesions were excised from dried leaf samples and surface
sterilized for 30 s in 70% (v/v) ethanol, 60 s in 10% (v/v)
NaOCl, and rinsed for 60 s in sterile deionized H2O. Surface-
sterilized lesions were transferred to 1.5% (w/v) tap water agar
plates amended with ampicillin (100µgmL−1), streptomycin
(100µgmL−1), and neomycin (50µgmL−1), and grown at room
temperature for 7 days. Subsequent hyphal growth was sub-
cultured to V8-potato-dextrose agar (10 g potato-dextrose agar,
3 g CaCO3, 15 g agar, 150mL V8 juice in 850mL sterile deionized
H2O; V8PDA) plates and incubated at room temperature under
white light for 5 days. To induce sporulation, sterile deionized
H2O was applied to hyphae and flattened gently with a glass rod;
the plate was then incubated at room temperature under near-UV
for 24 h, followed by 15◦C in darkness for 24 h. For each isolate, a
single conidium was transferred to a new V8PDA plate. Mycelial
plugs of this culture were stored at −80◦C and these were used
for all subsequent testing.
In vitro Fungicide Sensitivity Testing
Mycelial plugs of monoconidial Ptt isolates were inoculated
on V8PDA plates and incubated at room temperature under
white light for 5 days. Sporulation was induced as described
above. Spores were harvested by flooding plates with 10mL
sterile deionized H2O and scraping the mycelia with glass rod.
The suspension was then filtered through two layers of sterile
cheesecloth and centrifuged at 3220 g for 10min at 4◦C. The
pellet was resuspended in 1mL sterile deionized H2O and spore
density estimated using a haemocytometer. The suspension was
adjusted to produce a stock with a spore concentration of 1 ×
104mL−1.
Pure technical grade fungicide compounds were dissolved in
absolute ethanol, and serial dilutions were prepared so that the
total volume of fungicide/solvent added to each well was kept
TABLE 1 | Details and fungicide sensitivity phenotype of isolates used in
this study.
Year Location Phenotype Isolate(s)
1996 Kalannie, WA TEB− 9179
1996 Merredin, WA TEB− 9193
1996 Badgingarra, WA TEB− 9238
1996 Pithara, WA TEB− 9241
1996 Esperance, WA TEB− 9254
1996 Jerramungup, WA TEB− 9264
2003 Wongan Hills, WA TEB− 10914
2009 Wongan Hills, WA TEB− W1
2012 Amelup, WA TEB− U9
2013 aKojonup, WA TEB+ Ko103, Ko309
2013 aKojonup, WA TEB− Ko310, Ko603
2014 aBeverley, WA TEB+ 14P9FG30, 14P9FG32, 14P9FG34,
14P9FG40, 14P9FG43
2014 Kendenup, WA TEB− 14P9FG430, 14P9FG435
2014 Woogenellup, WA TEB− 14P9FG431, 14P9FG433, 14P9FG436
2014 Porongurup, WA TEB− 14P9FG432
2014 Tenterden, WA TEB− 14P9FG434, 14P9FG437
2014 Mt Barker, WA TEB− 14P9FG438
2014 Arthur River, WA TEB− 14P9FG439
2014 Takaralup, WA TEB− 14P9FG440
2015 0631546E
6186387N
TEB− 15FRG002, 15FRG003
2015 South Stirling, WA TEB− 15FRG094, 15FRG095, 15FRG096,
15FRG097, 15FRG098
2015 Esperance, WA TEB− 15FRG133, 15FRG134, 15FRG135,
15FRG136
2015 Bakers Hill, WA TEB+ 15FRG146
2015 Kojonup, WA TEB− 15FRG153, 15FRG154, 15FRG155,
15FRG156, 15FRG162, 15FRG164,
15FRG167, 15FRG168
2015 Kendenup, WA TEB− 15FRG161, 15FRG172, 15FRG182,
15FRG183, 15FRG184, 15FRG185,
15FRG186, 15FRG197, 15FRG198,
15FRG199, 15FRG212
2015 West Arthur, WA TEB+ 15FRG219
2015 Dandaragan, WA TEB+ 15FRG220
2015 Wickepin, WA TEB− 15FRG222
2015 Tenterden, WA TEB− 15FRG223
2015 aFreeling, SA TEB− 15FRG252, 15FRG253, 15FRG254,
15FRG255, 15FRG256
2015 aWilliams, WA TEB− 15FRG275, 15FRG276
Location: WA, Western Australia; SA, South Australia. Phenotype: TEB−, tebuconazole-
sensitive; TEB+, tebuconazole-resistant.
aBait trial.
constant. A master mix was prepared consisting of 0.5% (v/v)
fungicide stock, or an equivalent volume of ethanol (for the zero
fungicide control), in Yeast Bacto Acetate liquid medium (10 g
yeast extract, 10 g Bacto peptone, 10 g sodium acetate in 1 L sterile
deionized H2O; YBA). A total volume of 95µL was added to each
well of a 96-well microtiter plate. The range of concentrations
used for each fungicide was adapted to the response of each
isolate to the fungicide tested in order to obtain a dose-response
curve. In order to exclude the activity of alternative oxidase,
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salicylhydroxamic acid was included in the medium at a final
concentration 50 µM for tests involving azoxystrobin.
A 5 µL volume of spore stock was inoculated to 95 µL of
media with fungicide to a final concentration of 500 sporesmL−1;
at least two biological replicates with up to three technical
replicates were inoculated for each isolate. Immediately following
inoculation, optical density (OD) was measured at 405 nm
wavelength in a Synergy HT microplate reader (BioTek). Plates
were incubated for 96 h at room temperature in darkness, after
which ODwas again measured. Final OD values were normalized
with readings taken immediately following inoculation. The
concentration of fungicide resulting in 50% reduction in growth
(EC50) was calculated in Microsoft Excel by linear regression of
log10-transformed percentage reduction in OD compared to zero
fungicide control, against log10-transformed concentration of
fungicide. Estimate of EC50 was made with the linear portion of
the dose response, using the formula EC50 = 10([log10(50)−b]/m),
from the regression y = m.log(concentration)+b. The resistance
factor (RF) of each resistant isolate was calculated as a ratio of
the EC50 to the mean EC50 of all sensitive isolates collected in
the years 1996 to 2012. All EC50 values were log10-transformed
prior to statistical analysis (Liang et al., 2015), statistical analysis
was performed with IBM SPSS (Statistical Product and Service
Solutions, version 24.0, Armonk, NY, USA). EC50 values of
populations were compared using Student’s t-test with the
significance threshold set at 5%; correlations between EC50 values
were determined with Spearman’s rank order correlation with the
significance threshold set at 1%.
Discriminatory Dose Screening
A 4mm-diameter mycelial plug taken from the colony edge
of a 5 day culture grown on V8PDA was inoculated to the
center of a YBA agar plate amended with tebuconazole to a
final concentration 10µgmL−1, or equivalent volume of ethanol
solvent for the zero fungicide control. Two biological replicates
were inoculated for each isolate and plates were incubated for
96 h at room temperature in darkness, after which time the
presence or absence of growth on the plate was visually assessed.
Isolates able to grow at 10µgmL−1 were considered to be
resistant.
Cloning and Sequencing of Cyp51A and
Cyp51B Genes
Mycelia of Ptt was snap-frozen in liquid nitrogen and ground
with tungsten beads in a Retsch MM301 Mixer-Mill (Retsch
GmbH). Genomic DNA was isolated using a Biosprint 15
instrument and Biosprint DNA Plant Kit (QIAGEN) as
per manufacturer’s instructions. For sequencing of Cyp51A
promoter, Cyp51B coding sequence and Cyp51B promoter,
PCR amplification was carried out in 50 µL reaction volume
containing 0.25µLMyTaqDNAPolymerase (5 UµL−1, Bioline),
10.0 µL 5× reaction buffer, 2.5 µL each forward and reverse
primer (5 µM; Table 2), 2.5 µL DNA template (100 ng µL−1),
and 32.25 µL H2O. PCR parameters were initial denaturation
at 94◦C for 2min, followed by 35 cycles of 94◦C for 30 s, 58◦C
for 30 s, and 72◦C for 2min, followed by a final extension at
72◦C for 5min. PCR products were purified with a GenElute PCR
Clean-Up Kit (Sigma). Purified PCR products were sequenced
by Macrogen (Seoul, South Korea). Sequences were assembled
and analyzed using Geneious 6 software (Biomatters), alignments
performed using ClustalW algorithm (Thompson et al., 1994)
with IUB scoring matrix, gap opening penalty 15, gap extension
penalty 6.66.
For cloning and sequencing of Cyp51A gene, PCR
amplification was carried out in a 50 µL reaction volume
containing 0.5 µL Phusion High Fidelity DNA Polymerase (2
U µL−1, Thermo Scientific), 10 µL 5× reaction buffer, 1.5 µL
DMSO, 5 µL dNTPs (2mM), 2.5 µL each forward and reverse
primer (10 µM; Table 2), 1µL genomic DNA template (100 ng
µL−1), 27 µL H2O. PCR parameters were initial denaturation
at 98◦C for 30 s, followed by 35 cycles of 98◦C for 10 s, 69◦C
for 30 s, and 72◦C for 1min, followed by a final extension at
72◦C for 10min. PCR products were purified as described
above. Purified PCR products were A-tailed with DyNAzyme
II DNA Polymerase (2 U µL−1, Thermo Scientific), ligated
into pGEM-T Easy Vector (Promega) as per manufacturer’s
instructions and transformed to XL10 Ultracompetent cells
(Agilent). Plasmid DNA was prepared with a GenElute Plasmid
Miniprep Kit (Sigma) and cloned inserts sequenced by Macrogen
(Seoul, South Korea). Sequences were assembled and analyzed
using Geneious 6 software (Biomatters), alignments performed
using ClustalW algorithm (Thompson et al., 1994) with Blosum
scoring matrix, gap opening penalty 10, gap extension penalty
0.5, free end gaps. Translated amino acid sequences were aligned
to the archetypal CYP51A (Mair et al., 2016) amino acid sequence
from A. fumigatus (GenBank accession no. AAK73659), and the
CYP51B sequence from P. digitatum (GenBank accession no.
ADO85402). Amino acid substitutions associated with resistance
are described with reference to the archetype “mutation label”
(italicized) throughout text as previously described (Mair et al.,
2016). Sequences have been deposited to GenBank (accession
numbers KX578217-KX578221).
Growth of Fungal Cultures and Nucleic
Acid Extraction for Quantitative PCR
Analysis and Sequencing
Isolates Ko103 and 9193 were inoculated in 60mL Fries liquid
medium Number 2 (Fries, 1938) to a concentration of 500
sporesmL−1 and grown at room temperature, 150 rpm in
darkness with three biological replicates per isolate of both
treatment and control cultures. Growth curve analysis of Ko103
and 9193 showed they had similar rates of growth (data not
shown). At 64 h post-inoculation, when cultures were in the
exponential phase of growth, tebuconazole in ethanol solution
was added to the media to a final concentration equivalent to
the EC50 of each respective isolate (EC50 = 3.9 µgmL−1 for
Ko103; 0.26 µgmL−1 for 9193) as described previously (Cools
et al., 2012). For the control cultures an equivalent volume of
ethanol solvent was added with no tebuconazole. At 112 h post-
inoculation, cultures were harvested and freeze-dried. RNA was
extracted with Trizol reagent (Invitrogen), treated with RNase-
Free DNase (QIAGEN), and purified with RNeasy Plant Mini Kit
(QIAGEN). cDNA synthesis was performed with iScript cDNA
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TABLE 2 | Oligonucleotide primers used in this study and their relevant characteristics.
Primer name Sequence 5′–3′ Description
PttCyp51A_1F ATGCTCTCCCTCCTCTTCCTC Forward primer for amplifying and sequencing Cyp51A
PttCyp51A_2F TACGACTGATTGAGCAAGAGGT Primer for sequencing Cyp51A
PttCyp51A_1R GAGATCGTGGTACAGGCTTG Primer for sequencing Cyp51A
PttCyp51A_3F GCATTCCAACGTCGTCAAAG Primer for sequencing Cyp51A
PttCyp51A_2R TTCGCTGTTGGCTGAGATAC Primer for sequencing Cyp51A
PttCyp51A_3R TTACCGCCTCTCCCAGC Reverse primer for amplifying and sequencing Cyp51A
PyrCyp51B_F1 AGTCGTCCACGCCTGTCG Forward primer for amplifying and sequencing Cyp51B
PyrCyp51B_R1 TCTTGTGTGATGAGGGTGACG Primer for sequencing Cyp51B
PyrCyp51B_F2 CATCACACAAGAATGCGAAGAC Primer for sequencing Cyp51B
PyrCyp51B_F3 AGGAAACCCTCCGTATCCAC Primer for sequencing Cyp51B
PyrCyp51B_R2 GAGTGTGTGGGAAGTGGGAAC Primer for sequencing Cyp51B
PyrCyp51B_R3 CACTCAACTATGCCAGGTGCT Reverse primer for amplifying and sequencing Cyp51B
PttCyp51A_Pro_F GGCTCATAAATGGCGGAAC Forward primer for amplifying and sequencing Cyp51A promoter
PttCyp51A_Pro_R AGGAAGAGGAGGGAGAGCAT Reverse primer for amplifying and sequencing Cyp51A promoter
PttCyp51B_Pro_F CGTCAAGGGCAGCCGGATTA Forward primer for amplifying and sequencing Cyp51B promoter
PttCyp51B_Pro_R AGGCGTGGACGACTTGGATGTA Reverse primer for amplifying and sequencing Cyp51B promoter
PttCyp51A_qPCR_F2 CGTGTACGACTGTCCCAATT Forward primer for RT-qPCR of Cyp51A
PttCyp51A_qPCR_R2 TGCTCAATCAGTCGTACGTG Reverse primer for RT-qPCR of Cyp51A
PttCyp51B_qPCR_F2 GGAGCAAACGTCCATCCTAG Forward primer for RT-qPCR of Cyp51B
PttCyp51B_qPCR_R2 TGGATACGGAGGGTTTCCTT Reverse primer for RT-qPCR of Cyp51B
PttActin_qPCR_F2 AATCGTCCGTGACATCAAGG Forward primer for qPCR of Actin
PttActin_qPCR_R2 GTACGACTTCTCCAAGCTGG Reverse primer for qPCR of Actin
WD001 TACTGTTCTACGCCCATCTCTC Forward primer for copy number qPCR of Cyp51A
WD002 AATGCAGAGGGCGAGAAG Reverse primer for copy number qPCR of Cyp51A
Synthesis Kit (BioRad). Genomic DNA was extracted using
the CTAB method (Saghai-Maroof et al., 1984). Concentration
of nucleic acid was quantitated using a Quantus Fluorometer
(Promega).
Quantitative PCR Analysis of Gene
Expression and Gene Copy Number
Quantitative RT-PCR (qPCR) analysis of theCyp51A andCyp51B
genes was conducted with QuantiTech SYBR Green Mastermix
(QIAGEN) on the BioRad CFX96 qPCR system usingActin as the
endogenous control (NCBI accession no. XM_003298028) and
primers listed inTable 2. All reactions were carried out with three
biological replicates and three technical replicates each. Relative
transcript abundances were calculated using the 2−1CT method
(Livak and Schmittgen, 2001). Statistical analysis was performed
with IBM SPSS, relative expression ratios were compared using
Mann–Whitney U-test with the significance threshold set at
5%. Gene copy number estimation by qPCR was performed as
previously described (Solomon et al., 2008), using four biological
replicates of genomic DNA and with Actin as the single copy
control.
Genome and RNA Sequencing
All RNA sequencing and cDNA library construction was
conducted by Novogene Bioinformatics Technology (Beijing,
China). RNA was sequenced using Illumina HiSeq platform.
Differential expression analysis was performed with edgeR
(Robinson et al., 2010). Statistical analysis was performed
with IBM SPSS, normalized read counts were compared using
Student’s t-test with the significance threshold set at 5%. Whole
genome sequencing and library construction was performed by
the Australian Genome Research Facility (Nedlands, Western
Australia) using Illumina MiSeq platform. Raw Illumina reads
were analyzed using FastQC (version 0.10.1; Andrews, 2010) for
quality control. The filtered sequencing reads were assembled
using SPAdes assembler (version 3.6.2; Nurk et al., 2013).
Coverage cut-off was disabled and the number of mismatches
and short indels was reduced by incurring SPAdes’ build-in post
processing module MismatchCorrector, which utilizes BWA tool
(Li and Durbin, 2009). The obtained assembly was scaffolded
using SSPACE (version 3.0; Boetzer et al., 2011). Annotation
of the scaffolded assemblies was achieved by using Prokka tool
(version 1.11; Seemann, 2014).
In silico Structural Modeling
Structural modeling of CYP51A sensitive allele 9193-A1 and
KO103-A1 allele carrying the F489L mutation was undertaken
using an automated homology modeling platform as previously
described for Mycosphaerella graminicola CYP51 and mutants
(Mullins et al., 2011). Ligand docking of azoles was also carried
out as previously described, and with AutoDock Vina (Trott and
Olson, 2010), cross-referenced and corroborated using the heme-
azole positions of the CYP51-azole co-crystallized structures of
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PDB:5EAB (Saccharomyces cerevisiae CYP51 complexed with S-
tebuconazole) and PDB:5EAF (Saccharomyces cerevisiae CYP51
complexed with fluquinconazole).
RESULTS
Identification of DMI Fungicide Resistance
in Ptt
The fungicide sensitivities of monoconidial Ptt strains collected
from 1996 to 2013 were determined in vitro via microtiter
assay in order to establish EC50 levels to several DMIs as
well as to fungicides from different mode of action groups.
Isolates were screened initially with tebuconazole, epoxiconazole,
and prothioconazole (Table 3), and a subset of these isolates
tested against QoI fungicide azoxystrobin and the SDHI
fungicide boscalid (Table S1). Two isolates, Ko103 and Ko309,
were identified with reduced sensitivity to tebuconazole (EC50
of 3.9 and 2.4µgmL−1, RF of 16.4 and 10.1, respectively)
compared to the isolates collected during 1996–2012 (EC50
range 0.06–0.34µgmL−1, mean EC50 = 0.24µgmL−1). These
two isolates also displayed a level of reduced sensitivity to
other triazole fungicides, including epoxiconazole (EC50 of
0.23 and 0.16µgmL−1, RF of 2.0 and 1.4, respectively) and
prothioconazole (EC50 of 0.18 and 0.12µgmL−1, RF of 2.7 and
1.6, respectively). By comparison, the EC50 values of the isolates
collected during 1996–2012 were for epoxiconazole 0.02–0.23
µgmL−1 (mean EC50 = 0.11µgmL−1) and for prothioconazole
0.03–0.21 µgmL−1 (mean EC50 = 0.07µgmL−1). The analysis
showed no significant differences in sensitivities of the DMI-
resistant isolates to the non-DMI fungicides azoxystrobin [t(10) =
−0.62, p = 0.548] and boscalid [t(9) = −0.65, p = 0.530],
compared to the wild-type.
The EC50 results from microtiter assays were used to
define a cut-off concentration in order to distinguish the
two tebuconazole sensitivity groups identified in the above
screening. A total of 58 isolates collected in 2014 and 2015
were pre-screened on a discriminatory dose of 10µgmL−1
tebuconazole (Table 1). Pre-screening identified a further eight
isolates showing a reduced sensitivity to tebuconazole (Table 1).
These eight new isolates were selected for more detailed
analysis by EC50 screening on the previously tested DMI
fungicides tebuconazole, epoxiconazole, and prothioconazole
(Table 3). These isolates identified in pre-screening showed
similar patterns of sensitivity to the original two resistant isolates
Ko103 and Ko309, with RFs to tebuconazole of 12–19.9 (mean
RF 16.5), to epoxiconazole 1.1–2.2 (mean RF 1.5), and to
prothioconazole 1.5–5.3 (mean RF 2.6). The reduced sensitivity
of the 10 isolates to DMIs was shown to be significant for
TABLE 3 | EC50 and RF values of Pyrenophora teres f. sp. teres isolates to tebuconazole, epoxiconazole, and prothioconazole.
Isolate Tebuconazole Epoxiconazole Prothioconazole
EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF
Ko103 3.9 (±0.9)a 16.4b 0.23 (±0.02) 2.0 0.18 (±0.04) 2.7
Ko309 2.4 (±0.2) 10.1 0.16 (±0.03) 1.4 0.12 (±0.01) 1.6
14P9FG30 4.1 (±0.5) 17.1 0.15 (±0.03) 1.3 0.25 (±0.04) 3.5
14P9FG32 3.8 (±0.5) 15.8 0.12 (±0.02) 1.1 0.38 (±0.08) 5.3
14P9FG34 4.8 (±0.6) 19.9 0.21 (±0.02) 1.8 0.17 (±0.02) 2.3
14P9FG40 4.2 (±0.3) 17.4 0.13 (±0.02) 1.1 0.11 (±0.01) 1.5
14P9FG43 3.3 (±0.8) 14.0 0.13 (±0.02) 1.1 0.12 (±0.02) 1.6
15FRG146 2.9 (±0.9) 12.0 0.23 (±0.06) 2.1 0.17 (±0.04) 2.3
15FRG219 5.3 (±0.7) 22.3 0.25 (±0.01) 2.2 0.18 (±0.03) 2.4
15FRG220 3.3 (±0.4) 13.8 0.16 (±0.02) 1.5 0.16 (±0.03) 2.2
M = 16.5 M = 1.5 M = 2.6
9179 0.32 (±0.04) 0.21 (±0.04) 0.04 (±0.002)
9238 0.15 (±0.03) 0.05 (±0.01) 0.03 (±0.004)
9241 0.34 (±0.02) 0.17 (±0.01) 0.07 (±0.01)
9264 0.11 (±0.03) 0.04 (±0.01) 0.03 (±0.003)
10914 0.33 (±0.10) 0.23 (±0.04) 0.21 (±0.04)
U9 0.06 (±0.01) 0.02 (±0.01) 0.05 (±0.02)
Ko310 0.70 (±0.33) 0.17 (±0.04) 0.10 (±0.02)
Ko603 0.44 (±0.08) 0.08 (±0.01) 0.10 (±0.03)
9193 0.26 (±0.05) 0.12 (±0.02) 0.06 (±0.01)
9254 0.28 (±0.05) 0.06 (±0.004) 0.03 (±0.01)
W1 0.31 (±0.08) NDc ND
EC50 values are the mean of at least two independent experiments.
a± Standard error of the mean.
bResistance Factor (EC50/mean EC50 of isolates 1996–2012).
cND, Not determined.
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tebuconazole [t(12.56) = −12.32, p < 0.001], prothioconazole
[t(18) = −4.57, p < 0.001], and epoxiconazole [t(10.99) = −2.41,
p = 0.035], compared to the wild-types. There were significant
positive correlations between the EC50 values of tebuconazole-
prothioconazole [rS(18) = 0.777, p < 0.001], tebuconazole-
epoxiconazole [rS(18) = 0.570, p = 0.009], and prothioconazole-
epoxiconazole [rS(18) = 0.593, p= 0.006].
These 10 tebuconazole-resistant isolates, and two
tebuconazole-sensitive isolates, 9193 and 9254, were also
tested for their sensitivity to two additional DMI compounds,
propiconazole and metconazole (Table 4). The 10 tebuconazole-
resistant isolates also showed reduced sensitivity to these DMIs
compared to the two tebuconazole-sensitive isolates, with RFs to
propiconazole of 5.7–9.7 (mean RF 7.7), and to metconazole 8.9–
25.3 (mean RF 13.8). The two tebuconazole-sensitive isolates,
9193 and 9254, and six tebuconazole-resistant isolates (Ko103,
Ko309, 14P9FG40, 14P9FG43, 15FRG146, and 15FRG220) were
also tested for their sensitivity to a further four additional DMI
compounds: triadimenol, triticonazole, difenoconazole, and
prochloraz (Table 5). The six tebuconazole-resistant isolates
also showed reduced sensitivity to these DMIs compared to the
two tebuconazole-sensitive isolates, with RFs to triadimenol of
3.1–4.2 (mean RF 3.4), to triticonazole 10.8–19.1 (mean RF 15.6),
to difenoconazole 10.2–15.2 (mean RF 12.4), and to prochloraz
17.8–31.7 (mean RF 27.7).
DMI Resistance in Ptt Is Correlated with
Mutation F489L in One of the Cyp51A
Alleles
Sequencing of the 1.68 kb Cyp51B gene in all the tebuconazole-
resistant isolates and in seven tebuconazole-sensitive isolates
(W1, 9193, 9254, 9179, 9238, 9264, and 10914) showed the
TABLE 4 | EC50 and RF values of Pyrenophora teres f. sp. teres isolates to
metconazole and propiconazole.
Isolate Metconazole Propiconazole
EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF
Ko103 1.8 (±0.5)a 11.4b 0.65 (±0.13) 7.1
Ko309 2.7 (±0.5) 16.7 0.51 (±0.08) 5.7
14P9FG30 2.4 (±0.6) 15.3 0.77 (±0.11) 8.5
14P9FG32 2.3 (±0.2) 14.8 0.74 (±0.12) 8.2
14P9FG34 1.4 (±0.2) 8.9 0.61 (±0.13) 6.7
14P9FG40 1.6 (±0.2) 10.0 0.70 (±0.08) 7.7
14P9FG43 1.7 (±0.3) 10.6 0.58 (±0.05) 6.4
15FRG146 1.9 (±0.4) 11.7 0.75 (±0.06) 8.2
15FRG219 4.0 (±0.5) 25.3 0.78 (±0.08) 8.5
15FRG220 2.2 (±0.3) 13.7 0.89 (±0.05) 9.7
M = 13.8 M = 7.7
9193 0.11 (±0.02) 0.12 (±0.03)
9254 0.21 (±0.05) 0.06 (±0.02)
EC50 values are the mean of at least two independent experiments.
a± Standard error of the mean.
bResistance Factor (EC50/mean EC50 of isolates 1996–2012).
existence of a single allele of Cyp51B in all cases. There were no
changes observed when the sequences were aligned to theCyp51B
reference of Ptt isolate 0–1 deposited in GenBank (accession no.
NW_003523339).
Genome sequencing of the isolates Ko103 and 9193 showed
they both carried two copies of the Cyp51A gene (data
not shown). This observation was later confirmed by qPCR
(Figure S2). Subsequently, both copies of the Cyp51A gene
were cloned and sequenced in 10 tebuconazole-resistant isolates
and in three tebuconazole-sensitive isolates (W1, 9193, 9254),
revealing the existence of five alleles of Cyp51A, assorted into
three genotypes (Table 6). Sensitive isolates W1 and 9254 both
carry the two alleles termed W1-A1 and W1-A2, which differ by
only one nucleotide at base 259, resulting in a substitution of
arginine for glycine at position 87 of the translated amino acid
sequence. The sensitive isolate 9193 carries the alleles termed
9193-A1 and 9193-A2, with both of these alleles differing from
the W1-A1 and W1-A2 alleles at four nucleotides including
three non-synonymous changes, resulting in the point mutations
V133I, K419E, and K421E in the amino acid sequences. The
two 9193 alleles differ between each other by seven nucleotides
including four non-synonymous changes, resulting in the point
mutations H40Y, H66Y, G67R, and N110S in the amino
acid sequence. The amino acid sequence of allele 9193-A1
is identical to that of the reference sequence of isolate 0–1
from GenBank (accession no. XP_003303644; Figure 1). All 10
resistant isolates also carry the 9193-A2 allele as well as a unique
allele labeled KO103-A1. The KO103-A1 allele is identical to
the 9193-A1 allele except for a C to A transversion at base
1467 resulting in a substitution of leucine for phenylalanine
at position 489 of the amino acid sequence. Thus, the F489L
amino acid substitution represents the only polymorphism of
Cyp51A segregating the resistant from the sensitive isolates.
An alignment of the amino acid sequences of the CYP51A
variants to the CYP51A amino acid sequence from A. fumigatus
(Figure 1) revealed the F489L substitution to be orthologous to
the archetype F495I mutation associated with DMI resistance in
A. fumigatus and is therefore given the mutation label F495L.
The F495L amino acid substitution is also homologous to
the DMI resistance mutation F506I in P. digitatum CYP51B
(Figure 1).
The F495L Mutation in Cyp51A Results in
Reduced Binding Affinity to Azole
Fungicides
Structural modeling was performed on the CYP51A variants
9193-A1 and KO103-A1 docked with the DMIs difenoconazole,
prochloraz and tebuconazole (Table 7, Figure 2). The KO103-A1
allele with the F495L substitution had a lower predicted binding
affinity for all three DMIs tested when compared to the 9193-
A1 allele carrying F495. There were consistently more residues
in close proximity to the docked azole compounds in KO103-A1
than in 9193-A1, suggesting a general diminishing of the binding
cavity, but particularly markedly around the M288-H292 helical
region. Residues A289 and H292 are consistently implicated to
be in close proximity to the bound azole compounds in both
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TABLE 5 | EC50 and RF values of Pyrenophora teres f. sp. teres isolates to triadimenol, triticonazole, difenoconazole, and prochloraz.
Isolate Triadimenol Triticonazole Difenoconazole Prochloraz
EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF EC50 (µgmL
−1) RF
Ko103 56.5 (±7.8)a 4.2b 26.3 (±6.0) 19.1 0.15 (±0.05) 15.2 0.29 (±0.03) 31.2
Ko309 51.7 (±7.1) 3.8 22.1 (±4.2) 16.0 0.10 (±0.05) 10.2 0.24 (±0.07) 25.7
14P9FG40 43.3 (±1.9) 3.2 18.3 (±2.7) 13.2 0.10 (±0.01) 10.5 0.28 (±0.04) 30.0
14P9FG43 41.1 (±6.6) 3.1 14.9 (±1.8) 10.8 0.10 (±0.03) 10.5 0.17 (±0.02) 17.8
15FRG146 41.1 (±7.0) 3.1 24.5 (±1.7) 17.7 0.14 (±0.03) 14.4 0.28 (±0.06) 30.0
15FRG220 43.2 (±3.6) 3.2 23.2 (±4.1) 16.8 0.14 (±0.02) 13.6 0.30 (±0.08) 31.7
M = 3.4 M = 15.6 M = 12.4 M = 27.7
9193 21.1 (±2.1) 2.22 (±0.41) 0.011(±0.002) 0.008 (±0.001)
9254 5.8 (±1.5) 0.54 (±0.02) 0.009 (±0.002) 0.011 (±0.002)
EC50 values are the mean of at least two independent experiments.
a± Standard error of the mean.
bResistance Factor (EC50/mean EC50 of isolates 1996–2012).
TABLE 6 | Translated amino acid sequences of Cyp51A alleles found in Pyrenophora teres f. sp. teres.
Allele Polymorphism in amino acid sequence Found in isolate
40 66 67 87 110 133 419 421 489
W1-A1 H H G G N I K K F W1a, 9254a
9193-A1 H H G G N V E E F 9193a
KO103-A1 H H G G N V E E L Ko103b, Ko309b, 14P9FG30b, 14P9FG32b, 14P9FG34b, 14P9FG40b,
14P9FG43b, 15FRG146b, 15FRG219b, 15FRG220b
W1-A2 H H G R N I K K F W1, 9254
9193-A2 Y Y R G S V E E F 9193, Ko103, Ko309, 14P9FG30, 14P9FG32, 14P9FG34, 14P9FG40, 14P9FG43,
15FRG146, 15FRG219, 15FRG220
aTebuconazole-sensitive isolate.
bTebuconazole-resistant isolate.
9193-A1 and KO103-A1, but in KO103-1 the close proximity is
extended to M288 and G290.
The changes associated with CYP51A 9193-A1 do not prevent
heme iron-coordinated binding of difenoconazole, prochloraz,
or tebuconazole. In KO103-A1, however, there is substantial
conformational change compared with 9193-A1, the foremost
being movement of the long I helix at the amino terminal end
around M288, leading to a constriction of the binding cavity; and
the insertion of a section of beta turn, including F217 and V218,
into the border of the heme cavity. In that regard, it is interesting
to note that tebuconazole was predicted to dock adjacent toM288
in 9193-A1. The site of the primary mutation, F489, is itself
within a 3 Å range of prochloraz in 9193-A1, and L489 (F495L) is
again adjacent to prochloraz in KO103-A1 and is one of the three
amino acids, along with F217 and M288 that prevents normal
docking of tebuconazole.
DMI Resistance in Ptt Is Associated with
Overexpression of the Cyp51A and Cyp51B
Genes
To investigate the role of Cyp51A and Cyp51B expression on
resistance, qPCR analysis and RNA sequencing of sensitive and
resistant isolates induced with their respective EC50 tebuconazole
concentrations were undertaken. Both experiments confirmed
constitutive expression of the Cyp51B gene in the ethanol control
samples (Figures 3A, 4A). By contrast, Cyp51A1/A2 alleles were
not detectable (RNA sequencing) or detected at extremely low
levels (qPCR, no distinction between alleles A1 and A2) in the
control samples of either isolate (Figures 3B, 4B). Conditions
that imposed a similar growth constraint on both isolates
were used for studying the expression of Cyp51A and Cyp51B
under fungicide induction (Cools et al., 2012). qPCR analysis
comparing the tebuconazole-sensitive isolate 9193 and the
resistant isolate Ko103 grown at their respective EC50 revealed
the expression of Cyp51B to be 1.6-fold higher in the resistant
compared to the sensitive isolate, although this difference was
not considered significant (Mann–Whitney U = 33, p = 0.546;
Figure 3A). The expression of Cyp51A was significantly higher
in Ko103 than in 9193 (Mann–WhitneyU = 0, p< 0.001), with a
5.2-fold increase in the resistant compared to the sensitive isolate
(Figure 3B). These observations were validated by read density
analysis of RNA sequencing data of the two isolates showing
the expression of Cyp51B to be 1.6-fold higher in the resistant
compared to the sensitive isolate at EC50 tebuconazole, which
was considered significant {t(4) = 3.44, p = 0.026, 95% CI [794,
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FIGURE 1 | Alignment of amino acid sequences corresponding to the different Cyp51A alleles. Translated amino acid sequences of the five P. teres f. sp.
teres Cyp51A alleles detected in this study (KO103-A1, 9193-A1, 9193-A2, W1-A1, W1-A2), aligned with CYP51A from the reference isolate 0–1 (GenBank accession
(Continued)
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FIGURE 1 | Continued
no. XP_003303644), Aspergillus fumigatus CYP51A (ASPEFU, GenBank accession no. AAK73659), and Penicillium digitatum CYP51B (PENIDI, GenBank accession
no. ADO85402). Alignment is numbered according to A. fumigatus CYP51A. The positions of polymorphisms in the P. teres f. sp. teres CYP51A sequences are
indicated by yellow boxes. The amino acid sequence of 9193-A1 is identical to the 0–1 reference sequence. KO103-A1 differs from 9193-A1 by the amino acid
substitution F489L, orthologous to F495I in A. fumigatus and F506I in P. digitatum. Alignment generated in Geneious version 6.1 software (Biomatters) using ClustalW
algorithm with Blosum scoring matrix, gap opening penalty 10, gap extension penalty 0.5, free end gaps.
TABLE 7 | Residues within 3 Å of the docked azoles and predicted binding affinities (kcal mol−1) of difenoconazole, prochloraz, and tebuconazole
docked in 9193-A1 and KO103-A1.
Difenoconazole Prochloraz Tebuconazole
9193-A1 E152, A289a, H292, N293, N356, A357, I358 Q166, I170, A289, H292, A357, I358, H359,
S360, M488, F489
L148, I170, N171, M288, A289, H292
Binding affinity −10.600 −9.100 −9.500
KO103-A1 F217, V218, L219, M288, A289, G290, H292,
N356, A357, I358, M488
F217, V218, P220, M288, A289, G290, H292,
A357, I358, H359, S360, M488, L489
F217, V218, I284, M288, A289, G290, H292,
L489
Binding affinity −9.100 −7.500 −8.200b
aResidues in bold are part of the M288-H292 helical region of the binding cavity that are found in close proximity to the azole-heme complex.
bPredicted binding affinity based on alternative docking location.
7436]; Figure 4A}. The expression of the Cyp51A genes were on
average 3.6-fold higher in the resistant compared to the sensitive
isolate when grown at their respective tebuconazole EC50; RNA
sequencing analysis also confirmed that both copies of Cyp51A
were expressed in both isolates and further dissected the relative
expression of the two Cyp51A copies (Figure 4B). The expression
levels of the Cyp51A1 and Cyp51A2 alleles were shown to be 5.3-
fold higher {t(4) = 8.46, p= 0.001, 95% CI [275, 545]} and three-
fold higher {t(4) = 6.78, p = 0.002, 95% CI [299, 714]} in Ko103
than in 9193, respectively. The Cyp51A2 gene was revealed to be
expressed at a significantly higher level than the Cyp51A1 gene in
both isolate 9193 {2.6-fold higher, t(4) =−6.84, p= 0.002, 95%CI
[−219, −92.4]} and in Ko103 {1.5-fold higher, t(4) = −2.92, p =
0.043, 95%CI [−491,−12.7]}. The results support the conclusion
that Cyp51A expression appears to be induced by the presence of
tebuconazole, especially in the resistant isolate.
Cyp51 Gene Overexpression in Ptt Is Not
Correlated with Changes in the Nucleotide
Sequences of the Cyp51A or Cyp51B
Promoters
Initially primers were used to amplify and sequence a 571 bp
region upstream of the start codon of the Cyp51B gene in isolates
9193 and Ko103, revealing no changes at the nucleotide level
between the two isolates. Subsequent genome sequencing of the
two isolates allowed the investigation to be further extended to
1000 bp upstream of the start codon of the Cyp51B gene in
isolates 9193 and Ko103, and also revealed no changes at the
nucleotide level between the two isolates. The sequence data
generated allowed the analysis of a region extending over 800
bp upstream of the start codons of both of the Cyp51A1 and
A2 alleles, revealing that the sequence of the Cyp51A1 and A2
putative promoters are identical between isolates 9193 and Ko103
(Figure S3). However, comparing the promoter sequence of
the Cyp51A1 and Cyp51A2 paralogs revealed several differences
between them, including an 8 bp insert located 471 bp upstream
of the start codon in the Cyp51A2 promoter.
DISCUSSION
In Australia, emergence of multi-DMI resistance in Ptt has been
observed in isolates collected from the years 2013 onwards.
Resistant isolates were geographically widely dispersed across
Western Australia, originating in Kojonup, Beverley, Bakers Hill,
West Arthur, and Dandaragan (Figure 5). We used bait trials in
these studies so as to increase the likelihood of finding resistant
isolates even when their frequency is still low. We therefore
cannot reliably estimate the frequency of the resistant isolates,
but it is clearly at a significant level in Western Australian
populations of Ptt (Table 1).
Resistant isolates displayed high resistance factors (mean
RF > 10) to tebuconazole, metconazole, triticonazole,
difenoconazole, and prochloraz, and lower RFs (mean RF
< 10) to epoxiconazole, prothioconazole, propiconazole, and
triadimenol (Table 3). Isolates of this phenotype showed no
observable reduction in sensitivity to QoI or SDHI fungicides.
Although Ptt is a sexually recombining organism its reproduction
occurs mostly asexually (Lehmensiek et al., 2010); therefore
analysis of simple-sequence repeat markers conducted shortly
after the emergence of a mutation should reveal whether
the mutants are clonally related and derive from a single
event, or whether this resistance has emerged multiple times
independently as a response to the common selection pressure of
azole fungicide use.
Two potential mechanisms of resistance have been observed
in our data and may both contribute to the resistant phenotype.
The observation that all DMI-resistant strains, and none of
the DMI-sensitive strains, carry an identical point mutation
resulting in the amino acid substitution F495L of the DMI target
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FIGURE 2 | Structural modeling of 9193-A1 and KO103-A1 docked with difenoconazole, prochloraz, and tebuconazole. 9193-A1 (top row), KO103-A1
(bottom row). Fungicides in ball and stick, heme groups in cyan, showing the location of each azole and interacting residues shown in yellow and labeled. (A)
Difenoconazole and (B) prochloraz occupy the binding cavities of 9193-1 and KO103-1 unhindered. (C) Tebuconazole binding is unhindered in 9193-1, but blocked
by F217, M288, and L489 (in purple) in the KO103-1 mutant, as indicated by the spatial conflict. F217 is located away from the binding cavity in 9193-1.
CYP51A, strongly supports the relationship of this mutation
with azole fungicide resistance. The structural modeling and
analysis of the CYP51A sensitive allele 9193-A1 and resistant
allele KO103-A1 suggests that the F495L mutation has led to
notable rearrangements of particular structural elements of the
heme cavity, leading to localized constrictions, bringing more
residues into proximity with all three of the azoles tested, most
acutely in the region of the cavity adjacent to the docking site
for the bulky less elongated tebuconazole, which provides a
structural mechanism for the observed lack of sensitivity to azoles
in isolates carrying the allele KO103-A1.
This conclusion is reinforced by an alignment of the Ptt
CYP51A with its ortholog from A. fumigatus, showing that the
F489Lmutation is orthologous to F495I inA. fumigatusCYP51A.
This mutation is associated with resistance to the DMI fungicides
itraconazole and posaconazole in A. fumigatus (Mellado et al.,
2007; Liu et al., 2015). Structural modeling of A. fumigatus
CYP51A has shown that the F495I residue is close to the substrate
binding pocket (Liu et al., 2016). The F495L mutation in Ptt
and A. fumigatus CYP51A is also homologous to the F506I
substitution in P. digitatum CYP51B, which is correlated with
resistance to prochloraz (Wang et al., 2014). In A. fumigatus the
F495I mutation has been found only in combination with other
changes in the CYP51A amino acid sequence such as L98H or
S297T (Mellado et al., 2007; Lockhart et al., 2011). In P. digitatum,
the F506I substitution is found only in combination with G459S
in CYP51B (Wang et al., 2014). By contrast, in Ptt the F495L
mutation is the sole polymorphism of CYP51A to be found only
in resistant and not in sensitive isolates.
Point mutations in the amino acid sequence of CYP51
targets occurring in conjunction with overexpression of the
corresponding genes have been described in DMI-resistant
strains of several pathogens. The predominant mechanisms of
azole resistance in A. fumigatus is termed CYP51A TR/L98H,
a combination of the amino acid substitution L98H with a 34
bp tandem repeat in the Cyp51A promoter that results in an
up to eight-fold increase in expression (Mellado et al., 2007;
Snelders et al., 2008; Lockhart et al., 2011). In Pyrenopeziza
brassicae, the isolates with the highest levels of azole resistance
have a combination of inducible Cyp51B overexpression and the
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FIGURE 3 | Effect of tebuconazole on Cyp51A and Cyp51B gene expression in isolates 9193 and Ko103. (A) qPCR confirmed constitutive expression of the
Cyp51B gene in the ethanol control samples of both isolates. When grown under conditions that imposed a similar constraint on both isolates (EC50 tebuconazole),
the expression of Cyp51B was found to be 1.6-fold higher in the resistant compared to the sensitive isolate. (B) qPCR showed Cyp51A (no distinction between alleles
A1 and A2) to be expressed at extremely low levels in the control samples of either isolate. When grown under conditions that imposed a similar constraint on both
isolates (EC50 tebuconazole), the expression of Cyp51A was 5.2-fold higher in the resistant compared to the sensitive isolate. Cyp51A expression appears to be
induced by the presence of tebuconazole. Mean relative expression of genes of interest calculated by 2−1CT, normalized to Actin as the endogenous control
(±Standard error of the mean, n = 3 biological replicates, three technical replicates per biological replicate). ***p < 0.001 (Mann–Whitney U-test).
amino acid substitution S508T (S524T) (Carter et al., 2014). In
azole-resistant isolates of Erysiphe necator, the CYP51B Y136F
(Y137F) amino acid substitution co-occurs with a 1.4 to 19-
fold increase in expression (Rallos and Baudoin, 2016). In our
study, induced overexpression of both the Cyp51A genes (A1
and A2) and the Cyp51B gene has been demonstrated in a
DMI-resistant strain compared to a DMI-sensitive wild-type
and this may contribute to the observed phenotype of DMI
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FIGURE 4 | RNAseq read counts of Cyp51A1, Cyp51A2, and Cyp51B in isolates 9193 and Ko103 under tebuconazole treatment. (A) Mean RNAseq read
counts of Cyp51B. Analysis of isolates Ko103 and 9193 showed the expression of Cyp51B to be 1.6-fold higher in the resistant compared to the sensitive isolate
when grown under their corresponding EC50 tebuconazole. (B) Mean RNAseq read counts of Cyp51A1 and Cyp51A2. Expression of Cyp51A1 and Cyp51A2 was
not detectable (zero reads) in the control samples of either isolate. Read density analysis of RNA sequencing data of the two isolates confirmed that both copies of
Cyp51A were expressed in both isolates. The expression levels of the Cyp51A1 and Cyp51A2 alleles in Ko103 and 9193 cultures amended with their corresponding
EC50 tebuconazole, were shown to be 5.3- and 3-fold higher in Ko103 than in 9193, respectively. Differential expression analysis and read count normalization
achieved by edgeR (±Standard error of the mean, n = 3 biological replicates). *p < 0.05; **p < 0.01 (Student’s t-test).
cross-resistance. Alternatively, the observed increased expression
of the Cyp51 genes may be a compensatory mechanism to
maintain sterol composition if the F495L mutation results in
reduced CYP51A enzyme efficiency. Subsequent heterologous
expression and enzymatic activity studies should determine the
effect of the observed mutation on the function of CYP51A,
and may clarify the role of target overexpression and dissect its
contribution to DMI resistance.
Overexpression of Cyp51 is typically caused by insertions
of tandem repeats or transposable elements in the promoter
region (Price et al., 2015). As described above, in A. fumigatus
overexpression of Cyp51A is caused by a 34 bp tandem
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FIGURE 5 | Map of Western Australia showing geographic origin of Pyrenophora teres f. sp. teres isolates. Leaf samples were collected from 23 separate
locations in Western Australia from a combination of field trips and bait trials. Locations 1, 2, and 14 were specially designed bait trials. Resistant strains of P. teres f.
sp. teres were isolated from samples taken in locations 1–5. Adapted from “Outline map of Australia” (http://www.ga.gov.au/metadata-gateway/metadata/record/
gcat_61754) by Commonwealth of Australia (Geoscience Australia), used under CC BY 4.0.
duplication in the promoter (Mellado et al., 2007). Similarly in
P. digitatum a 126 bp tandem repeat acts as a transcriptional
enhancer for Cyp51A expression in DMI-resistant isolates
(Hamamoto et al., 2000). In Pyrenopeziza brassicae insertions
of 46, 151, and 232 bp in the predicted promoter region of
Cyp51B are correlated with overexpression (Carter et al., 2014).
In azole-resistant isolates of Zymoseptoria tritici, overexpression
of the Cyp51B gene is correlated with a 120 bp insertion in
the predicted promoter region (Cools et al., 2012). In Ptt we
were unable to find any changes at the nucleotide level in
the promoter regions of Cyp51A1, Cyp51A2, and Cyp51B of a
strain overexpressing these genes, when compared to a wild-type.
An overexpressing Cyp51 phenotype that cannot be linked to
promoter changes has previously been reported in azole-resistant
isolates of some fungal pathogens including A. fumigatus and
Villosiclava virens (Arendrup et al., 2010; Wang et al., 2015).
Future studies of possible trans-regulatory changes due to
mutations in transcription factors, and analyses of the DNA
methylation and histone modification of the promoters may
elucidate whether such regulatory elements could be involved in
the overexpression of these genes in Ptt.
Interestingly, although Ptt shares the same host as P. teres f. sp.
maculata (Ptm), the other forma specialis responsible for SFNB
and the predominant form of net blotch disease in Australia
(McLean et al., 2010;Murray and Brennan, 2010), azole resistance
in this pathogen has not been reported yet. This can probably
be explained by the comparatively lower exposure of Ptm to
DMI fungicides through time. Until comparatively recently, Ptt
was the predominant net blotch form in Western Australia.
Ptm was first reported in southern Western Australia in 1995,
having previously only been found in the northern wheatbelt.
Ptm appears to have spread in south-west WA from that time
aided by the introduction of stubble retention practices and SFNB
sensitive varieties including Franklin (1989), Gairdner (1998),
and Baudin (2002) (Paynter et al., 1999; Paynter and Fettell, 2011;
Gupta et al., 2012). The prevalence of these varieties in high
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rainfall areas together with treatment with significant levels of
DMI fungicides (Geoff Thomas, personal communication) may
underlie the emergence of resistance in Ptt first. However, current
coexistence of Ptt and Ptm raises the possibility of fungicide
resistance transfer to Ptm by rare hybridization events (McLean
et al., 2014). A more likely scenario, however, is independent
acquisition of resistance by Ptm under the same selection
pressures. In view of the results presented here, there is an urgent
need for adequate anti-resistance management strategies in both
types of net blotch disease.
The evolution of new DMI resistant strains in Ptt would
provide additional challenges to the barley industry. Improved
knowledge of fungicide resistance evolution and of the molecular
mechanisms by which this occurs will be necessary to implement
suitable control strategies that will reduce the likelihood of
fungicide resistance outbreaks.
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